News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Exciting Time for Biotech in New Jersey     6/26/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015
Gilead (GILD)'s Next-Gen HIV Drug Heads to the FDA, Stock Soars     4/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     3/2/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It?     2/23/2015
TRICON: Chimerix (CMRX): Antivirals Are Undergoing a Renaissance, As Infectious Disease Comes Front and Center     2/18/2015
FDA Green Lights Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ) HIV Pills     1/30/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD)     1/20/2015
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact     12/29/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada     12/9/2014
Results Of City of Hope Clinical Trial Supports Change To Standard Of Care For HIV Lymphoma     12/5/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014

News from Around the Web
Vitamin D May Help Fight HIV, Penn State University Study     6/19/2015
Dirty Needles Spread HIV In Indiana As Pain Pills Injected     3/30/2015
Give HIV Drugs To Healthy Gay Men, UK Medical Research Council (MRC) Reveals     2/25/2015
Bill Gates Predicts An HIV Vaccine By 2030     1/30/2015
Birth Control Shot Linked To Increased HIV Risk, University of California, Berkeley (CAL) Study     1/12/2015
The Reason Why Experimental HIV Vaccines Backfire, Emory University Study Suggests     1/7/2015
New Technique For Bioengineering Stem Cells Shows Promise In HIV Resistance, University of California, Davis (UCD) Study     1/2/2015
AIDS Drug Also Offers Protection Against Malaria, Yale University Study Finds     12/22/2014
University of Oxford Research Suggests Ability Of HIV To Cause AIDS Is Slowing     12/2/2014
2nd Baby Cured Of HIV Relapses, Lancet Reveals     10/3/2014
Teen’s Organs Rejected Because He’s Gay     8/18/2014
Two Cancer Patients "Cured" Of AIDS After Bone Marrow Transplants, St. Vincent Hospital Study     7/21/2014
Joep Lange, The Physician-Scientist Before Medical Diplomat     7/21/2014
Top AIDS Researchers Killed In Malaysia Airlines Crash, Renowned Scientist Joep Lange Among Dead     7/21/2014
AIDS Epidemic May Be Over By 2030 – United Nations Reveals     7/17/2014

Press Releases
International AIDS Vaccine Initiative Release: AIDS Vaccine Candidate Successfully 'Primes' Immune System In Animal Models     6/19/2015
CytoDyn Cleared By FDA To Start Phase III Of First Injectable Antibody For HIV     6/9/2015
Aphios Completes Enrollment In Phase I/II Clinical Trial Towards An HIV Cure     6/2/2015
European Medicines Agency Validates Gilead (GILD)’s Marketing Application For Fixed-Dose Combination Of Emtricitabine And Tenofovir Alafenamide For HIV Treatment     5/28/2015
Johnson & Johnson (JNJ) Expands IP Policy To Create Broad Access In 128 Countries For Development Of New And Optimized HIV Medicine Formulations For Children Living With HIV     5/11/2015
Mologen AG (MOLGF.PK): Aarhus University Hospital Initiates MGN1703 Study In HIV Patients     5/8/2015
ViiV Healthcare Begins Phase III Programme With dolutegravir/rilpivirine Combination For HIV Maintenance Therapy     5/6/2015
CytoDyn Submits Phase 3 Protocol To FDA After Agreement On Protocol Synopsis     5/4/2015
Mechanism Of Action Of ABIVAX's First-in-class Anti-HIV Drug Published Today In Peer-Reviewed Journal Retrovirology     4/13/2015
NIH Funds Study Of Fully Personalized Immunotherapy AGS-004 Combined With A Latency Reversing Therapy For The Treatment Of HIV     4/1/2015
Argos Therapeutics, Inc. (ARGS) Director Of Immunology To Present At HIV Vaccines Meeting     3/20/2015
Case Western Reserve University Release: Common Herpes Medication Reduces HIV-1 Levels, Independent of Herpes Infection     3/13/2015
HIV-Positive: Is The Treatment Worse Than The Condition, Asks Journal Of American Physicians And Surgeons     3/9/2015
Gilead (GILD) Announces SVR12 Rates From Phase III Study Evaluating Harvoni For The Treatment Of Chronic Hepatitis C In Patients Co-Infected With HIV     2/27/2015
The Black AIDS Institute In Partnership With Novant Health Brings Health Screenings To Black College Students At CIAA     2/27/2015

//-->